GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for acireductone dioxygenase (B2VAA3)

Analyse AlphaFold monomer V2.0 prediction for acireductone dioxygenase (B2VAA3) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2VAA3
Type
protein
Length
179 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x5ce0D3c69518629Fa692C944CeBE0a3596343B38
Molecule
Acireductone dioxygenase
UniProt
B2VAA3
Pockets
1 · best druggability 0.60

Structure

1 distinct chain · 23% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAcireductone dioxygenaseprotein17923% helix, 32% strandB2VAA3

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11050.600.8619empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.